Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12467963 | 0.88 | — | — | |
| SCHEMBL14493711 | 0.83 | — | — | |
| SCHEMBL27522393 | 0.80 | TSHR (0.35) | TSHRNFKB1CYP2C19 | |
| SCHEMBL1305578 | 0.79 | TSHR (0.33) | TSHRNFKB1CYP2C19 | |
| SCHEMBL13675276 | 0.76 | KDM4E (0.32) | — | |
| SCHEMBL29742365 | 0.74 | TSHR (0.31) | TSHRNFKB1CYP2C19 | |
| SCHEMBL3661697 | 0.74 | TSHR (0.31) | TSHRNFKB1CYP2C19 | |
| SCHEMBL28594770 | 0.74 | TSHR (0.31) | TSHRNFKB1CYP2C19 | |
| SCHEMBL20712947 | 0.74 | TSHR (0.31) | TSHRNFKB1CYP2C19 | |
| SCHEMBL3159770 | 0.74 | TSHR (0.35) | TSHRNFKB1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115108992-A | Preparation method of 6-chloro-2-methyl-2H-indazole-5-amine | 浙江手心制药有限公司 | 2022-09-27 | — | — | CN | claimed |
| CN-114436789-A | Green and environment-friendly veratraldehyde synthesis method | 宁夏宁泰科技有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-111825678-A | Preparation method of carbamatinib | 连庆泉 | 2020-10-27 | — | — | CN | claimed |
| EP-3755675-B1 | ACCELERATED PEROXIDE-CURED RESIN COMPOSITIONS HAVING EXTENDED OPEN TIMES | ARKEMA INC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12486381-B2 | Accelerated peroxide-cured resin compositions having extended open times | ARKEMA INC. (US) | 2025-12-02 | — | — | US | disclosed |
| EP-3559153-B1 | EFFICIENT CURATIVE FOR FREE RADICALLY-CROSSLINKABLE POLYMERS | ARKEMA INC (US) | 2025-07-30 | — | — | EP | disclosed |
| CN-118693319-B | Flow battery based on high-concentration iron electrolyte stabilized by recovered lithium ions | 长沙理工大学 | 2024-12-20 | — | — | CN | disclosed |
| CN-118693319-A | Flow battery based on high-concentration iron electrolyte stabilized by recovered lithium ions | 长沙理工大学 | 2024-09-24 | — | — | CN | disclosed |
| US-12095068-B2 | Rechargeable non-aqueous lithium-air battery cell comprising a solid organic catalyst | TOYOTA MOTOR EUROPE (BE) | 2024-09-17 | — | — | US | disclosed |
| US-20240117156-A1 | ACCELERATED PEROXIDE-CURED RESIN COMPOSITIONS HAVING EXTENDED OPEN TIMES | ARKEMA INC (US) | 2024-04-11 | — | — | US | disclosed |
| US-20240097130-A1 | Lithium Secondary Battery and Manufacturing Method for the Same | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 2024-03-21 | — | — | US | disclosed |
| EP-1837350-A1 | PROCESS FOR PRODUCTION OF MODIFIED POLYMERS AND MODIFIED POLYMERS PRODUCED THEREBY | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2007-09-26 | — | — | EP | disclosed |
| US-20070191516-A1 | Process for the synthesis of amine ethers | CIBA SPECIALTY CHEMICALS CORP. | 2007-08-16 | — | — | US | disclosed |
| US-20070106023-A1 | Siloxane-acrylate interpenetrating networks and methods for producing the same | XEROX CORPORATION (US) | 2007-05-10 | — | — | US | disclosed |
| EP-1777237-A1 | Modified butyl rubber composition | The Yokohama Rubber Co., Ltd. (JP) | 2007-04-25 | — | — | EP | disclosed |
| WO-2006017357-A1 | A PROCESS FOR THE PREPARATION OF ROSUVASTATIN INVOLVING A TEMPO-MEDIATED OXIDATION STEP | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2006-02-16 | — | — | WO | disclosed |
| EP-0569334-B1 | Process for preparing N-methoxy derivatives of 4-hydroxy-2,2,6,6-tetramethylpiperidine and 2,2,6,6-tetramethyl-4-piperidone | CIBA GEIGY AG (CH) | 1995-02-15 | — | — | EP | disclosed |
| US-5374729-A | Treating N-oxyl hindered amine with hydrogen peroxide and a peroxide-decomposing transition metal salt in the presence of dimethyl sulfoxide | CIBA-GEIGY CORPORATION (US) | 1994-12-20 | — | — | US | disclosed |
| EP-0569334-A1 | Process for preparing N-methoxy derivatives of 4-hydroxy-2,2,6,6-tetramethylpiperidine and 2,2,6,6-tetramethyl-4-piperidone | CIBA-GEIGY AG (CH) | 1993-11-10 | — | — | EP | disclosed |
| EP-0350223-A2 | Polyacetal resin composition | POLYPLASTICS CO. LTD. (JP) | 1990-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191516-A1 | Process for the synthesis of amine ethers | AOC2, AOX1, AKR7A2 | TSHR 1398/4885NFKB1 3387/4885CYP2C19 122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.